On May 11, 2015, Connecticut Governor Dannel P. Malloy signed into law Public Act 15-4, “An Act Concerning Reporting of Payments by Manufacturers to Independently-Practicing Advanced Practice Registered Nurses” (P.A. 15-4). P.A. 15-4 is effective from passage and revises a law enacted in 2014 that mandates certain manufacturers to report to the Department of Consumer Protection (DCP) payments or other transfers of value to advanced practice registered nurses (APRNs). The current law (Conn. Gen. Stat. § 21a-70f) is modeled on the federal Physician Payments Sunshine Act (Sunshine Act), which requires certain manufacturers to report annually to the Centers for Medicare and Medicaid Services certain payments or other transfers of value to physicians.

Currently, manufacturers of drugs, devices, biologicals, or medical supplies payable under Medicare or Medicaid are required to report to the DCP certain payments or other transfers of value provided to APRNs. Such reports must provide the same information as required under the Sunshine Act, including, but not limited to, the amount, date, nature, and form (that is, cash, in-kind items or services, stocks or other ownership interests, or any other form of payment or transfer of value) of the payment or value conferred to the APRN. The current law requires that manufacturers submit reports to the DCP quarterly, with the first report due by July 1, 2015.